Pound for Pound

This has been an interesting week in Spine/Biologics. You may remember when Ramius decided to go on the offensive against Orthofix last year regarding the perceived mismanagement/acquisition of Blackstone. Apparently, some other investors thought highly of that tactic as investors of Alphatec and Osteotech have decided to employ a similar strategy. Osteotech has started their process in a similar way, with a written letter slamming the contributions of its current CEO and executive management team. Alphatec investors, however, decided to play even more hardball by expressing their desire to investigate “insider trading” and “misleading information provided to investors” with some of the company’s Directors.

We are curious to know what you all know. Is this just another controlling investment group trying to forcefully impose its will on a public company, or is there fire where there appears to be smoke.

Please leave the information you are aware of to spur conversation regarding this topic.

Posted By

Josh Sandberg has been recruiting specifically in the musculoskeletal industry for over 8 years. Throughout this time, he has been able to have a positive impact on his client’s businesses. With an educational background in Business Management, Josh is adept to discern which people will be the best fit for the company he is searching for by understanding how candidates will incorporate with the company’s culture and operational nuances. His experience as an executive in a start-up business has granted him the ability to understand what is takes to thrive in a hands–on environment, where desire and dedication are paramount for success.